Related references
Note: Only part of the references are listed.Biodegradable interstitial release polymer loading a novel small molecule targeting Axl receptor tyrosine kinase and reducing brain tumour migration and invasion
S-Y Yen et al.
ONCOGENE (2016)
Inhibiting receptor tyrosine kinase AXL with small molecule inhibitor BMS-777607 reduces glioblastoma growth, migration, and invasion in vitro and in vivo
Julia Onken et al.
ONCOTARGET (2016)
Small molecule inhibition of Axl receptor tyrosine kinase potently suppresses multiple malignant properties of glioma cells
Mikaella Vouri et al.
ONCOTARGET (2015)
EZH2 Protects Glioma Stem Cells from Radiation-Induced Cell Death in a MELK/FOXMI-Dependent Manner
Sung-Hak Kim et al.
STEM CELL REPORTS (2015)
AXL induces epithelial-to-mesenchymal transition and regulates the function of breast cancer stem cells
M. K. Asiedu et al.
ONCOGENE (2014)
The receptor tyrosine kinase Axl regulates cell-cell adhesion and stemness in cutaneous squamous cell carcinoma
M. A. Cichon et al.
ONCOGENE (2014)
Brain tumor senescence might be mediated by downregulation of S-phase kinase-associated protein 2 via butylidenephthalide leading to decreased cell viability
Mao-Hsuan Huang et al.
TUMOR BIOLOGY (2014)
EZH2 as a potential target in cancer therapy
Michael T. McCabe et al.
EPIGENOMICS (2014)
Targeting Cancer Stem Cells for Treatment of Glioblastoma Multiforme
Der-Yang Cho et al.
CELL TRANSPLANTATION (2013)
Understanding glioma stem cells: rationale, clinical relevance and therapeutic strategies
Atique U. Ahmed et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2013)
CD133 silencing inhibits sternness properties and enhances chemoradiosensitivity in CD133-positive liver cancer stern cells
Xi Lan et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2013)
CD133 Is Essential for Glioblastoma Stem Cell Maintenance
Paola Brescia et al.
STEM CELLS (2013)
Cancer-initiating cells derived from established cervical cell lines exhibit stem-cell markers and increased radioresistance
Jacqueline Lopez et al.
BMC CANCER (2012)
Cancer stem cells and drug resistance: the potential of nanomedicine
Serguei Vinogradov et al.
NANOMEDICINE (2012)
A restricted cell population propagates glioblastoma growth after chemotherapy
Jian Chen et al.
NATURE (2012)
Promotion of Glioblastoma Cell Motility by Enhancer of Zeste Homolog 2 (EZH2) Is Mediated by AXL Receptor Kinase
Martina Ott et al.
PLOS ONE (2012)
Butylidenephthalide Suppresses Human Telomerase Reverse Transcriptase (TERT) in Human Glioblastomas
Po-Cheng Lin et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Celecoxib and radioresistant glioblastoma-derived CD133+ cells: improvement in radiotherapeutic effects Laboratory investigation
Hsin-I Ma et al.
JOURNAL OF NEUROSURGERY (2011)
SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer
Theresia Wilbertz et al.
MODERN PATHOLOGY (2011)
Local interstitial delivery of z-butylidenephthalide by polymer wafers against malignant human gliomas
Horng-Jyh Harn et al.
NEURO-ONCOLOGY (2011)
Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells
F. Orzan et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2011)
Expression of glioma stem cell marker CD133 and O6-methylguanine-DNA methyltransferase is associated with resistance to radiotherapy in gliomas
Jie He et al.
ONCOLOGY REPORTS (2011)
Inhibition of Mer and Axl Receptor Tyrosine Kinases in Astrocytoma Cells Leads to Increased Apoptosis and Improved Chemosensitivity
Amy K. Keating et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival
Christine Gjerdrum et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Correlation of CD133, OCT4, and SOX2 in Rectal Cancer and Their Association with Distant Recurrence After Chemoradiotherapy
Susumu Saigusa et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Enhanced MDR1 Expression and Chemoresistance of Cancer Stem Cells Derived from Glioblastoma
Eiichi Nakai et al.
CANCER INVESTIGATION (2009)
EZH2 Is Essential for Glioblastoma Cancer Stem Cell Maintenance
Mario-Luca Suva et al.
CANCER RESEARCH (2009)
How powerful is CD133 as a cancer stem cell marker in brain tumors?
Jin-Xiang Cheng et al.
CANCER TREATMENT REVIEWS (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Axl as a potential therapeutic target in cancer: role of Axl in tumor growth, metastasis and angiogenesis
Y. Li et al.
ONCOGENE (2009)
SOX2 Silencing in Glioblastoma Tumor-Initiating Cells Causes Stop of Proliferation and Loss of Tumorigenicity
Rosaria Maria Rita Gangemi et al.
STEM CELLS (2009)
Brain tumor stem cells as research and treatment targets
Takuichiro Hide et al.
BRAIN TUMOR PATHOLOGY (2008)
Orphan nuclear receptor, Nurr-77 was a possible target gene of butylidenephthalide chemotherapy on glioblastoma multiform brain tumor
Po-Cheng Lin et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Vascular endothelial growth factor in astroglioma stem cell biology and response to therapy
Petra Knizetova et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao et al.
NATURE (2006)
Analysis of gene expression and chemoresistance of CDI33+ cancer stem cells in glioblastoma
Gentao Liu et al.
MOLECULAR CANCER (2006)
The natural compound n-butylidenephthalide derived from Angelica sinensis inhibits malignant brain tumor growth in vitro and in vivo3
Nu-Man Tsai et al.
JOURNAL OF NEUROCHEMISTRY (2006)
The antitumor effects of Angelica sinensis on malignant brain tumors in vitro and in vivo
NM Tsai et al.
CLINICAL CANCER RESEARCH (2005)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma
R Galli et al.
CANCER RESEARCH (2004)
Identification of human brain tumour initiating cells
SK Singh et al.
NATURE (2004)
Cancerous stem cells can arise from pediatric brain tumors
HD Hemmati et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro
TN Ignatova et al.
GLIA (2002)
Stem cells, cancer, and cancer stem cells
T Reya et al.
NATURE (2001)
A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia
GG Wulf et al.
BLOOD (2001)
Share Paper
